matched across the maximum available eMLC field width demonstrated a therapeutic (80% of maximum dose) depth range of 2.1 -6.8 cm. Field matching was particularly challenging at lower beam energies (6 -12 MeV) due to the wider penumbrae and angular distribution of electron scattering. An eMLC isocentric electron breast boost was planned and compared with the conventional applicator fixed source-to-surface distance (SSD) plan, showing similar target coverage and dose to critical structures. The mean dose to the target differed by less than 2%. The low bremsstrahlung dose from the 7 cm thick MLC leaves had the added advantage of reducing the mean dose to the whole heart. Isocentric delivery using an extendable eMLC means that treatment room re-entry and repositioning the patient for SSD set-up is unnecessary. Monte Carlo simulation can accurately calculate the fluence below the eMLC and subsequent patient dose distributions. The eMLC generates similar dose distributions to the standard electron applicator but provides a practical method for more complex electron beam delivery.
INTRODUTION
Electron beam therapy is typically administered under fixed source-to-surface distance (SSD) conditions using an electron applicator and a custom lead alloy insert. It is a common modality for treating superficial tumours of the chest wall. Clinical evidence shows the benefit of boosting the breast tumour excision site with electrons, for example (Bartelink et al. 2001) . The potential for electron breast boost geographic misses has been identified, highlighting the need for accurate tumour bed localisation on a daily basis (Fraser et al. 2010) . The potential for dose calculation inaccuracies due to approximations made by commercial planning software has also been shown (Coleman et al. 2005) . In addition to the accuracy improvements introduced by using Monte Carlo-based dose calculation (Chetty et al. 2007) , electron beam therapy would also benefit from more accurate and precise techniques of delivery.
Complex and precise electron dose delivery is an active area of research, particularly the use of modulated electron and mixed (x-ray and electron) beam therapy techniques (Li et al. 2000 , Ma et al. 2003 , Gauer et al. 2010 , Surucu et al. 2010 , Alexander et al. 2011 . Modulated electron beam therapy provides a method of conformal treatment and has been shown to provide a reduction in dose to distal organs-at-risk and critical structures (Ma et al. 2003 , Jin et al. 2005 . Conventional methods for electron beam collimation are labour and time intensive in their construction and are considered inadequate for use in the sequential delivery of multiple complex fields. A number of authors have investigated the use of either the x-ray multi-leaf collimator (pMLC) or a dedicated electron multi-leaf collimator (eMLC) for un-modulated or modulated electron beam delivery (Lee et al. 2000 , Hogstrom et al. 2004 , Gauer et al. 2008 , Al-Yahya et al. 2007 , Klein et al. 2008 ). Lee et al. (2000) investigated two methods of electron beam collimation: (1) using the existing photon multi leaf collimators (pMLC) in a helium atmosphere to reduce in-air electron scatter, and (2) using a MLC specifically designed for electron beam collimation located at the level of the last scraper of the 25 × 25 cm 2 applicator on a Varian accelerator. Significant improvements, particularly in the dose profile penumbra, were reported when the treatment head air was replaced with the helium based system. Simulations were also performed on an electron specific MLC with unfocused tungsten leaves 1.5 cm thick and 0.5 cm wide which provided sufficient collimation for modulated electron fields. Hogstrom et al. (2004) proposed a retractable eMLC used for un-modulated or intensity modulated therapy which could (a) retract to 63 cm source-to-collimator distance (SCD) for arc therapy, or deploy to (b) 80 cm or (c) 90 cm SCD for isocentric and SSD set-ups, respectively. The Gauer et al. designed, evaluated (2006) and characterised (2008) an add-on eMLC with interchangeable distance holders for variable SCD (72 cm or 84 cm) and isocentric delivery on a Siemens Primus accelerator. The final eMLC design consisted of two banks of 24 brass leaves with height and width of 1.8 cm and 0.6 cm, respectively. Attachment and gantry stability was evaluated and found to result in a maximum displacement of 0.6 mm. The dosimetric properties, including field size dependence, field abutment and leakage, of the eMLC were evaluated. Dose profiles and percentage depth dose curves were compared with that of the standard applicator demonstrating a 0.8 -0.4 cm larger penumbra and build-up effect (limited to energies up to 14 MeV). Klein et al. (2008) used the 120 leaf pMLC on a Varian accelerator to develop and evaluate narrow (1 -10 cm) beam segments for modulated electron treatments at 6 -20 MeV using Monte Carlo methods. The study employed shorter source-to-surface distances (70 -85 cm) in order to improve the beam penumbrae. Monte Carlo planning was then performed on idealised phantom and clinical cases for segmented and dynamic leaf delivery (Klein et al. 2009 ). Sparing of distal organs at risk was reported, however, it was also noted that the use of shorter SSDs may be clinically impractical due to potential collisions and some treatment sites may need to be treated at larger SSD (>75 cm), degrading the penumbra and plan resolution. Jin et al. (2008) investigated modulated electron therapy using the pMLC on Siemens Primus accelerator. A Monte Carlo method of inverse planning was developed. Again, a shortened SSD (60 cm) was employed to improve the penumbra of 6 -15 MeV electron beams. A treatment consisting of 22 segments was planned and delivered on a breast phantom with measurements and simulations reported to agree to 2% / 1 mm.
It can be concluded that the current commercially available x-ray MLCs are generally unsuitable for electron beam collimation at nominal SSD (100 cm). Electron beams should ideally be collimated (in air) within 10 cm of the skin surface to reduce the size of the penumbra and maintain beam flatness, especially at lower (more widely scattered) beam energies. This would also aid matching and dose uniformity at beam junctions in modulated or abutted fields (Steel et al. 2009 , Eldib et al. 2010 . Studies which utilised the pMLC for electron beam collimation utilised a shortened SSD in order to improve the penumbra. A dedicated retractable eMLC may be the optimal method for electron beam collimation. This could be placed in close proximity (5 -10 cm) to the patient to provide an adequate penumbra and resolution and then remotely retracted to allow concomitant x-ray treatment.
This paper is concerned with characterisation of an extendable x-ray MLC for collimation of the full set of clinical electron beams available (6 -21 MeV) on a linear accelerator. Previous studies (e.g. Hogstrom et al. 2004 , Gauer et al. 2008 ) have generally investigated thinner, lower atomic number MLCs dedicated to electron beam delivery. The MLC was modelled in EGSnrc/MCRTP (Faddegon et al. 1998 ) and validated against water phantom dose measurements. The dose profile penumbrae and electron scattering were evaluated and dosimetric properties were compared with the standard applicator. Potential concerns, including bremsstrahlung x-ray dose and dose inhomogeneity in abutting fields of differing energy were investigated. The energy modulation possibilities and variation in therapeutic range achievable were examined for an wedge shaped dose distribution. A concomitant eMLC-collimated electron breast boost was planned using Monte Carlo calculations to demonstrate the isocentric treatment capabilities of the eMLC. The resulting plan was compared with the fixed SSD approach using a standard applicator.
MATERIALS AND METHODS

Extendable Multi-leaf Collimator
A TiGRT Dynamic Multi-leaf Collimator (DMLC H, LinaTech, Sunnyvale, CA, USA) was mounted on a Siemens Oncor linear accelerator (Siemens OCS, Erlangen, Germany) using 30 cm steel extenders at A wedge shaped dose distribution was planned using Monte Carlo simulation to demonstrate the eMLC energy modulation possibilities, and variation in target depth coverage achievable. The plan used a single isocentre and the six available electron beam energies (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) matched across the maximum available eMLC field size. To ensure that scatter from the eMLC banks was adequately modelled, dose profiles were measured (at 1 cm depth) for the the six adjacent fields 
Monte Carlo Simulation
Monte Carlo simulation was performed with the EGSnrc/BEAMnrc (Rogers et al. 1995) and MCRTP (Faddegon et al. 1998) codes. The treatment head above the eMLC was previously modelled to high accuracy for 6 -21 MeV electron fields and included simulation of the fringe magnetic field from the bending magnet (Faddegon et al. 2009 , O'Shea et al. 2011 . The eMLC was modelled in the EGSnrc user code MCRTP for 71.6 cm and 81.6 cm source-to-collimator distances (SCD) and 90 cm and 100 cm SSD for characterisation and comparison with measured data. Tungsten with a density of 19.3 g cm . The default maximum step size (SMAX) of 5 cm was used. The maximum fractional energy loss per step (ESTEPE) was set to 0.25 (default). Dose-to-water was calculated in a phantom containing 2.0 × 2.0 × 1.0 mm 3 voxels as part of the eMLC simulation. The
EGSnrc particle tracking variable LATCH was used to extract scattered electron and contaminant bremsstrahlung x-ray dose components for water phantom dose calculations.
Patient Plan
An electron breast boost was planned by Monte Carlo simulation using the methodology previously described and experimentally validated (using RANDO® phantom measurements) by Coleman et al. (2005) . 3D dose distributions were calculated on patient anatomical data in MCRTP for a conventional (SSD) applicator boost and an isocentric boost using the extendable eMLC. Table 1 compares the two plan configurations. The eMLC plan utilised the same isocentre as the tangential (whole breast irradiated) x-ray fields, while the applicator plan required a shift from the x-ray isocentre. The displacement of the eMLC leaves (field offset) in the direction of motion (Δx) and perpendicular to the the direction of motion (Δy) required to maintain the same treatment field position (on the patient skin)
as the applicator plan was calculated using: The 3D dose distribution calculated in MCRTP was imported into the PlanUNC planning software (Schreiber et al. 2006 ) which was used to compare isodose distributions and dose volume histograms (DVH) for the target (tumour bed), right lung and whole heart. DVHs were quantitatively compared by D95CTV: the minimum dose covering 95% of the target volume, V20lung (cm The eMLC penumbra was wider in all cases, however, it was within 0.3 -0.1 cm (6 -21 MeV) of the applicator penumbra when the airgap was reduced to configuration (i) above. This demonstrated that the difference in applicator and eMLC penumbra was mainly the result of the difference in airgap between the collimator and phantom surface. The clinically applicable Rmax dose profile parameters for the 10 × 10 cm 2 applicator and eMLC (SCD = 81.6 cm) fields at 100 cm SSD are compared in table 2. The dose profiles of the eMLC had lower off-axis dose fall-off as quantified by the penumbra and therapeutic field (distance between 80% relative dose points) widths. The penumbra of the 6 -21 MeV beams was 1.2 -0.4 cm wider and the therapeutic field widths were 0.85 -0.4 cm narrower than those of the 10 × 10 cm 2 applicator. Table 2 also includes the eMLC dose profile parameters at 90 cm SSD which are of more relevance to isocentric electron beam delivery. At 90 cm SSD the eMLC therapeutic field widths and penumbrae are within 0.5 cm and 0.3 cm of the corresponding applicator parameters, respectively. The eMLC should ideally generate a penumbra similar to the applicator. Electrons scattered from the eMLC had a marginal effect on the penumbra (figure 3); a maximum of 2.5% and 2.8% of the dose in the penumbra of the 10 × 10 cm 2 field size at 6 MeV and 21 MeV, respectively. For comparison, applicator contributed a maximum of 1.2% and 2.5% to the dose in the penumbra for the same energies. Electrons from the eMLC contributed 4.1% and 6.4% to the dose at Rmax on the central axis (i.e. to relative output) for 6 MeV and 21 MeV, respectively. The scattered electron contribution to the dose at Rmax for the 10 × 10 cm 2 applicator was lower, 1.1% and 3.4 % at 6 MeV and 21 MeV, respectively. The electron range in tungsten is short (only 0.5 cm for 20 MeV electrons) and the attenuation of the bremsstrahlung (x-rays) is high, therefore x-rays from the thick eMLC leaves had an insignificant contribution to the central axis dose at R max (figure 3), 0.2% at 21 MeV and an order of magnitude lower at 6 MeV. This contribution is negligible compared to the x-ray dose from the treatment head, which is a maximum of 5% at 21 MeV for a 40 × 40 cm For the applicator, the contribution of bremsstrahlung to the central axis dose at Rmax was < 0.1% and 0.4% at 6 MeV and 21 MeV, respectively. The contribution was much higher at the edge of the applicator-defined field, however, a maximum of 0.1% and 2.3 % for the 6 MeV and 21 MeV electron beams, respectively. This increase is the result of bremsstrahlung creation and transmission in the 1.3 cm thick brass scraper.
Figure 5. Percentage depth dose curves for 6 MeV and 21 MeV electron beams showing dose contribution from total electron beam (solid lines) and scattered electrons (dashed lines) and bremsstrahlung x-rays (dotted lines)
from the eMLC. The bottom surface of the leaf banks were at 81.6 cm SCD, the water surface was at 100 cm SSD.
Percentage depth dose curves (normalised to nominal Rmax) for the eMLC exhibited a lower surface dose (by 2.5 -4.2% for 6 -21 MeV), leading to a more deeply penetrating beam at 100 cm SSD (R80, 0.4 -0.21 cm) than the applicator defined fields ( figure 4 and table 3 ). The dose beyond the practical range (Dx) of the PDD was 0.1 -0.4% lower for the eMLC, primarily the result of reduced bremsstrahlung. Table 4 also includes the eMLC PDD parameters for 90 cm SSD which are very similar to those at 100 cm SSD (within 1.7% / 0.1 cm). The only notable differences were in the buildup dose and the depth of Rmax. Figure 5 shows the scattered electron and bremsstrahlung dose contributed by the eMLC to the PDD at 6 MeV and 21 MeV for a 10 × 10 cm 2 field at 100 cm SSD. The bremsstrahlung component was 5.0% and 2.0% of the dose at Rx for the 6 MeV and 21 MeV beams, respectively. For the applicator collimated field, the contribution at Rx was 7.5% and 6.0%, respectively (not shown).
Electrons scattered from the collimator contributed 3.6 -5.9% of the dose at 0.5 cm and 2.8 -3.9% at R 80 for the eMLC at 6 -21 MeV. The contribution was 1.7 -5.0% at 0.5 cm depth and 0.2 -0.6% at R 80 for the applicator collimated field. 
Leaf Resolution
It may be prudent when abutting electron fields to avoid open or shielded regions less than the penumbra width. These narrow fields could provide negligible enhancement to the dose distribution while increasing the scattered radiation in the treatment beam. It was therefore proposed that the eMLC leaf width be such that the dose below a closed leaf section is reduced to less than 50% of maximum dose (of the adjacent open sections). based on a quadratic fit of the leaf width versus maximum dose at 1 cm depth in the shield portion of the field. For this leaf width the dose at 6 MeV was reduced to 50% of maximum and 26.2, 16.0, 10.9,
8.30 and 7.2% for 9 -21 MeV, respectively. A thinner leaf width could be employed at the higher energies to achieve a 50% dose reduction. The leaf width required to provide a 50% reduction in dose was 0.7, 0.6 and 0.4 cm for 9 -15 MeV, respectively and < 0.4 cm at 18 -21 MeV. While limiting the leaf width may be prudent in most situations, the availability of thin leaves, conversely, may help improve the uniformity of the dose distribution at the junctions as a (thin) leaf could be added or removed on one side or the other of the junction. For example, the 18 / 21 MeV junction for the wedge field dose distribution (section 3.3) required a 2.5 mm gap. This could be approximated in the direction perpendicular to the leaf motion by having a one-leaf (0.2 cm) overlap between the fields.
Field Abutment
Matching of electron beams requires careful determination of the dose at the junction. A shift in the location of the field junction can be used to improve the dose distribution in certain situations. Figure 8 shows the dose profile across the field junction of 6 / 9 MeV and 18 / 21 MeV matched 5 cm square fields. The dosimetric effects of field overlaps and gaps of 0.2 cm on the phantom surface are included.
The wider penumbrae (6 MeV: 2.01 cm, 9 MeV: 1.49 cm) and scattering of the 6 MeV and 9 MeV beams meant that the dose across the junction was less homogeneous (max. dose -min. dose = 8.9%).
There was a hotspot of 106% in the junction region when the field edges were matched. This was reduced by 10% with a 0.2 cm gap. The sharper and comparable penumbrae of the 18 MeV (0.78 cm) and 21 MeV (0.73 cm) beams resulted in a more homogeneous dose distribution in the junction region (max. dose -min. dose = 4.7%). The sharper penumbra also meant that a shift in the junction position had a larger effect on the junction dose, increasing by 13.3% and reducing by 14.2% for a 0.2 cm overlap and gap, respectively. Isodose lines for the 18 / 21 MeV abutted field are plotted in figure 9 highlighting the hot and cold spots created by the various junction configurations. insert used with the applicator resulted in a wider lateral extension of the 2% and 5% isodose lines.
Patient Plan
Subsequently, the 2% isodose line encompassed a larger volume of the heart. The 7 cm thick eMLC leaves effectively eliminated bremsstrahlung in the shielded areas and the lateral extension of the 2% and 5% isodose lines was constricted. The mean dose to the target, right lung and whole heart was 91.8%, 15.8% and 3.0% for the applicator and 93.7%, 15.8% and 2.0%, for the eMLC plan, respectively. The DVHs for these structures are compared in figure 13 . D95CTV was 107.5% and 110.1% for the standard applicator and eMLC plans, respectively. V20lung was 510.4 cm These results are similar to those reported by a previous study (Gauer et al. 2008) , however, it is important to note that the thicker MLC employed in the current study did not introduce significant dose profile or PDD degrading collimator scatter. Additionally the eMLC dose profile and PDD parameters at 90 cm SSD -relevant to isocentric treatment delivery -were found to be in good agreement with the applicator parameters.
Scatter from the eMLC contributed 4.0 -6.3% (6 -21 MeV) to the dose at the depth of maximum dose, while the 7 cm thick leaves effectively eliminated bremsstrahlung leakage.
Field junctioning was a challenge at lower energies due to the wider penumbrae and angular distribution of electron scattering. A Monte Carlo calculated wedge shaped dose distribution consisting of 6 -21 MeV matched electron fields utilising the entire available field width of the eMLC exhibited a variation in therapeutic range of 2.1 -6.8 cm.
An isocentric eMLC breast boost plan showed similar target coverage and dose to organs-at-risk as the conventional applicator and fixed source-to-surface distance approach. Dose to the whole heart was reduced as a result of the very low bremsstrahlung contamination from the thick eMLC leaves.
Thick leaves may be advantageous for intensity modulated electron therapy techniques where the summation of bremsstrahlung dose from multiple fields can be a concern. The dose profiles and percentage depth dose curves for the eMLC and applicator exhibit very similar characteristics when the airgap between the collimator and patient surface is the same.
Monte Carlo simulation can accurately account for the eMLC and patient in dose calculation for treatment planning. Potential benefits of the eMLC include (i) faster delivery (no room re-entry to insert applicator), (ii) reduction in risk of positioning errors (using a single isocentre and no couch repositioning) and (iii) a practical method of modulated delivery.
